OriGene Technologies, Inc.
Search:    
About FL cDNA Clones RNAi Gene Expression Lysates and Proteins Antibodies Tissue Other Products Tech Support
orange
Blue-Ribbon Poly A+ RNA and Total RNA
Sure-Race CDNA 5' End Discovery Panels
Description
Format
Application
Rapid-Screen Arrayed cDNA Library Panels
cDNA Libraries
Molecular Tools
PrecisionShuttle ORF Vector System


OriGene cDNA clones in recent publications
Bat3 promotes the membrane integration of tail-anchored proteins J. Cell Sci., Jul 2010; 123: 2170 - 2178 [BAT3]

Caveolin-1 modulates HIV-1 envelope induced bystander apoptosis through gp41 J. Virol., Jul 2010; 84: 6515 - 6526 [CAV1]

Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression PNAS, Jul 2010; 107: 12210 - 12215 [PXDN]

HIV infection upregulates Caveolin 1 (Cav-1) expression to restrict virus production J. Virol., Jul 2010; 10.1128/JVI.00763-10. [CAV1]

View All Citations >>

SURE-RACE CDNA 5' END DISCOVERY PANELS

Traditional cDNA libraries frequently yield clones which are incomplete and where sequences representing mRNA 5' ends are missing. RACE technology, a PCR-based approach for rapid amplification of cDNA ends, has been particularly useful for completing the missing portions of cDNA clones and yielding full-length sequences of expressed gene regions.

To expand the utility of the RACE technology, OriGene has developed Sure-RACE cDNA 5 End Discovery Panels - PCR-ready RACE panel that allow simultaneous 5' end analysis of transcripts from 24 individual human tissues or 24 mouse tissues and developmental stages. Sure-RACE cDNA 5 End Discovery Panels contain double-stranded cDNAs that have been arrayed in multi-well plates.

  • Broad spectrum of tissues: scan 24 individual human or mouse tissues
  • High sensitivity: detect rare transcripts
  • Simultaneous analysis of alternatively spliced transcripts and alternate RNA start-sites

Sure-RACE Discovery Panels are designed with the recognition that an increasing number of genes have been identified that utilize alternate RNA start-sites resulting from tissue-specific or developmental stage-specific transcriptional promoters. In addition, an increasing number of genes have also been found to utilize alternate 5 exons, sometimes resulting in protein products with different N-terminal amino acid sequences.

 Terms of Use

Display Products
Copyright © 2010 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436


Reproduction of any materials from this website is strictly forbidden without permission.